PositiveID files Firefly DX patent

PositiveID Corp. filed an additional U.S. patent for its Firefly Dx pathogen detection device on Wednesday.

The hand-held device utilizes polymerase chain reactions (PCR) in order to produce a diagnostic result for a multitude of pathogens and other agents.
"We continue to strengthen our intellectual property position for Firefly Dx as our development and testing of the system progresses," PositiveID Chairman and CEO William Caragol said. "With the recent announcement that we are able to deliver positive test results within 20 minutes using our Firefly PCR chip, we are confident that our technology will not only work, but will represent a paradigm shift to the large PCR market."

Existing diagnostic tools can be cumbersome or impossible to use in some situations, particularly in remote areas or areas without the proper laboratory conditions. This device is portable and requires no outside source of electricity. Testing has shown that it is able to provide accurate results in a quick and efficient manner. The company said that results match lab techniques in accuracy and are able to streamline the diagnostic process.

This device's development process was funded by the U.S. Department of Homeland Security in order to better detect threats from airborne biological agents.

Organizations in this Story

U.S. Department of Homeland Security

Want to get notified whenever we write about U.S. Department of Homeland Security ?
Next time we write about U.S. Department of Homeland Security, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.